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Abstract 
 Rationale: We performed this study with the purpose of revealing different aspects of the systemic inflammatory response 
syndrome in peritonitis.  
 Objectives: The aim of the presentation was to make a research on some of the immune response mediators in 
secondary peritonitis and to observe their capacity to anticipate the evolution towards septic complications. 
  Methods and Results: We have undertaken a study on a group of 100 patients with acute diffuse peritonitis, between 
2009 and 2011, in which we have accomplished the dosage of IL-1, IL-6 and TNF  cytokines in the serum of patients, in 
dynamics, for 7 days by using the Elisa method. Subsequently, we have compared the results to the ones of a control group. The 
data obtained indicated high levels of proinflammatory cytokines in the patients who subsequently suffered an unfavorable evolution 
towards septic complications. 
 Discussion: The study of IL-1, IL-6 and TNF  blood dynamics, offers valuable information about the severity of a 
systemic inflammatory response syndrome in peritonitis. They can be valuable biomarkers in establishing the unfavorable evolution 
of patients, helping the physician to establish a sustained and specific treatment, even from the early phases of the illness. 
 
Keywords: interleukin, systemic inflammatory response syndrome, severe sepsis,  
septic shock, multiple organ dysfunctions. 
Introduction 
Acute diffuse peritonitis represents one of the 
most frequent surgical emergencies. In order to evaluate 
an efficient treatment with high chances of success, it is 
necessary to understand its evolution opportunity 
compared to the host’s immune system. 
A systemic inflammatory response syndrome 
accompanies severe forms of peritonitis. Its intensity is 
usually hard to anticipate, while merely relying on clinical 
criteria or usual laboratory analyses.  
Proinflammatory cytokines represent one of the 
most important mediators of the systemic inflammatory 
reaction, and, therefore, in recent years numerous studies 
have been trying to establish a link between their level in 
the patient’s serum and peritoneal fluid, and the 
probability of their bad evolution, despite the correctly 
performed surgical treatment. 
Because the study results are, most of the times 
contradictory, we have tried to formulate our own opinion, 
by studying the dimension of the systemic inflammatory 
reaction in an important number of patients with 
secondary peritonitis. Our goal was to find a link between 
the blood levels of cytokines, both at the beginning of the 
hospitalization and also during the postoperative period, 
and their evolution towards severe sepsis, septic shock 
and multiple organ dysfunction syndrome (MODS). 
Methods 
We have undertaken a prospective study on 100 
patients, hospitalized with the diagnostic of acute diffuse 
peritonitis produced by perforation, with ages between 16 
and 85 years. Moreover, we have analyzed 15 surgical 
patients without signs of infection or systemic 
inflammatory response syndrome, which represent the 
control group. 
We have accomplished the serum determination 
of proinflammatory cytokines (IL-1 , IL-6, TNF ), at the 
beginning of the hospitalization, after grading the patients 
according to the ACCP/SCCM criteria, as presenting 
secondary peritonitis with or without systemic 
inflammatory response syndrome. The patients with 
peritonitis and systemic inflammatory response syndrome, 
where also divided in:  
(i)  patients with sepsis/SIRS (depending 
on the possibility of identifying the germs in the peritoneal Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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fluid, intraoperatively taken or by the suspicion of 
infection);  
(ii)  patients with severe sepsis; and  
(iii)  patients with septic shock.  
We have also managed to determine these 
cytokines, in day 3 and day 7 postoperatively, and, 
subsequently, we divided the patients according to the 
general evolution in the same 4 groups, corresponding to 
the days of cytokine determination. We have determined 
the serum concentration of cytokines at admission in 15 
patients from the control group, after establishing the 
noninfectious character of the disease (the infectious 
disease represented exclusion criteria of the control 
group) and on day 1 postoperatively, knowing the fact that 
surgical/anesthetic stress may influence the blood 
dynamics of interleukins and TNF . 
The serum levels of IL-1, IL6 and TNF  were 
determined by the Elisa Sandwich method, while using 
Biosource and Invitrogen, the commercial kits of Elisa. 
We have accomplished the statistical analysis by using 
the SPSS 16 and Microsoft Excel program applications. 
Results  
To simplify the statistic analysis we have split the 
4 groups of patients with peritonitis (resulted after 
applying the ACCP/ACCM criteria), into two larger groups 
based on severity criteria: the first group was formed by 
patients with peritonitis, with or without systemic 
inflammatory response syndrome or sepsis, and the 
second one, formed by patients with peritonitis and septic 
complications (represented by severe sepsis, septic 
shock and MODS). In order to observe the capacity of 
different parameters to sustain the gravity diagnostic 
(peritonitis with or without septic complications) from 
hospitalization (day 1), we have applied two types of 
nonparametric tests: MANN-WHITNEY U and 
WILCOXON, obtaining the results presented in the 
following table:  
 
Table 1 
Dg D1  Age  D1IL-1  D1IL-6  D1TNF  
Predictive value 
(P) 
 
0,003 
 
0,913 
 
 0,001 
 
 0,001 
 
D3IL-1  D3IL-6  D3TNF   D7IL-1  D7IL-6  D7TNF  
 
0,941 
 
 0,001 
 
 0,001 
 
0,593 
 
 0,001 
 
 0,001 
 
It can be observed that besides IL-1 in day 1 
(preoperatively) and 3 and 7 (postoperatively), all the 
other parameters have a high statistic significance in 
sustaining the day 1 diagnostic (P<0,001). 
Table 2 resulted from Mann-Whitney U and 
Wilcoxon nonparametric test application while analyzing 
the patient’s diagnostic in day 3 postoperatively. 
 
Table 2 
Dg D3  Age  D1IL-1  D1IL-6  D1TNF  
Predictive value 
(P) 
 
 0,001 
 
0,674 
 
 0,001 
 
 0,001 
 
D3IL-1  D3IL-6  D3TNF   D7IL-1  D7IL-6  D7TNF  
 
0,053 
 
 0,001 
 
 0,001 
 
0,567 
 
 0,001 
 
 0,001 
 
The diagnostic value of IL-6 and TNF  levels in 
day 3 can be noted (i) to sustain the diagnostic of 
peritonitis with systemic inflammatory response 
syndrome, with or without septic complications on that 
day, and also (ii) the prognostic value of IL-6 and TNF , 
determined in day 1 (preoperatively), to predict the 
unfavorable evolution of patients (in all cases, P0,001). 
Moreover, the prognostic value of age was also noted, 
particularly, older patients who had a higher chance of 
developing postoperative septic complications. What can 
also be deduced from the table are the high maintenance 
levels of IL-6 and TNF  in day 7, in those patients who 
have developed earlier septic complications. There is no 
statistical significance for IL-1. 
When applying the same nonparametric tests for 
the gravity diagnostic in day 7, we have obtained the data 
from Table 3. 
 
Table 3 
Dg D3  Age  D1IL-1  D1IL-6  D1TNF  
Predictive value 
(P) 
 
0,002 
 
0,464 
 
0,002 
 
0,005 
 
D3IL-1  D3IL-6  D3TNF   D7IL-1  D7IL-6  D7TNF  
 
0,028 
 
 0,001 
 
0,004 
 
0,758 
 
 0,001 
 
 0,001 
 
In this case, we were able to identify the 
diagnostic value of proinflammatory cytokines, and also 
their prognostic value, by successive determinations in 
dynamics, for the severity diagnostic from day 7 (in all 
cases, P0,001). The age of the patients maintained its 
predictive value for the diagnostic on day 7, with a 
P=0,002. Also, for the day 7 diagnostic, the IL-1 levels 
lacked statistic significance. 
In order to observe the distribution of IL-6 values 
by using repeated measurements, depending on the 
presence or absence of septic complications in day 3 and 
7 postoperatively, we have made the general-linear 
graphics model type, illustrated in figures 1 and 2.  
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients with peritonitis but without septic 
complications; 
              1 – patients with peritonitis and septic complications. 
 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients with peritonitis but without septic 
complications; 
  1 – patients with peritonitis and septic complications. 
 
 
The dynamics of IL-6 levels, which are lower, 
can be observed in those patients without septic 
complications, both in day 3 and day 7 postoperatively, 
meaning that, the minimal levels, for those with septic 
complications and maximal levels, of those without such 
complications, are closer in day 7. Taking into account the 
control group from the postoperative period, we have 
compared the variation of IL-6 and TNF  levels, 
determined in day 7, with the three categories of 
diagnostic from that particular period, namely peritonitis 
with or without septic complications and the control group. 
The result is presented in the box plot graphics 3 and 4: 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients without septic complications in day 7 
(postoperatively); 
  1 – patients with septic complications in day 7 
(postoperativel(postoperatively); 
  3 – control group (postoperatively). 
 
 
Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients without septic complications in day 7 
(postoperatively); 
  1 – patients with septic complications in day 7 
(postoperativel(postoperatively); 
3 – control group (postoperatively). 
 
 
Making a comparative analysis of the two above-
mentioned graphics, we can notice different values of the 
two cytokines in those with or without septic complications 
in day 7 (with a higher level for IL-6) – diagnostic value. 
Regarding the comparison to the control group, the close 
values for IL-6 can be noticed in the patients with 
peritonitis but without complications and in the control 
group or TNF  case. The values are even higher in the Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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control group. The exceptions are stressed by the two 
graphics.  
To better mark out the statistic importance of IL-
6 and TNF  levels determined in the patient’s serum, in 
day 7, and, in order to differentiate between the three 
categories of diagnostics on that day, we have applied the 
Anova and Bonferroni tests, to determine the predictive 
values for the three diagnostics, together and grouped by 
two. In all the cases, the predictive values showed a 
significantly high statistic difference (P0,01), except for 
the comparison between the control group and those 
without septic complications, in the TNF  case, when we 
obtained a P>0,05, so, without a statistic significance 
(figures 5, 6). 
 
 
Figure 5  Mean values of IL-6 in day 7 postoperatively, in 
patients with peritonitis with or without septic complications, on 
that day, and in the postoperative control group. 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients without septic complications in day 7 
(postoperatively); 
  1 – patients with septic complications in day 7 
(postoperativel(postoperatively); 
  3 – control group (postoperatively). 
 
Figure 6 Mean values of TNF  in day 7 postoperatively, in 
patients with peritonitis, with or without septic complications, on 
that day, and in the postoperative control group. 
 
 
 
 
 
 
 
 
 
 
 
Legend: 0 – patients without septic complications in day 7 
(postoperatively); 
  1 – patients with septic complications in day 7 
(postoperativel(postoperatively); 
  3 – control group (postoperatively). 
Discussions 
Making an analysis of those exposed, connected 
with the diagnoses of day 1 (preoperatively), days 3 and 7 
(postoperatively), we have noticed that the diagnostic 
value of IL-6 and TNF  for sustaining the severity 
diagnoses, suited the period in which the dosage has 
been made (peritonitis with systemic inflammatory 
response syndrome with or without septic complications). 
It can be seen that, in order to differentiate between the 
control group and the patients who have peritonitis 
without septic complications, only IL-6 have a high 
statistical significance. Moreover, we have showed the 
predictive value of proinflammatory cytokines related to 
the unfavorable evolution of patients with peritonitis 
produced by perforation with systemic inflammatory 
response syndrome, towards severe septic complications 
in days 3 and 7 postoperatively. Also, we have noticed the 
predictive value of the age, older patients having higher 
chances to develop postoperative septic complications. 
The values determined for IL1  in the three periods of 
the study had no statistical significance. 
In comparison to the data resulted from our 
analysis, we will expose some data existing in the 
specialty literature, the outcome of numerous studies 
carried out on this theme.  
Sepsis may be difficult to distinguish from the 
other noninfectious conditions in patients hospitalized with 
altered general status, with clinical and biologic signs of 
acute inflammation [1, 2]. Therefore, it is necessary to 
make the difference between the systemic inflammatory 
response syndrome of noninfectious origin and different 
forms of severe sepsis, which cannot be made by clinical 
or laboratory signs [3]. Until now, no clinical or biological 
element has been unanimously accepted for sepsis 
diagnostic and its complications [4, 19], although there 
were numerous tries to correlate the plasmatic level of 
cytokines with the diagnostic of sepsis, severe sepsis and 
septic shock [2, 5, 6]. Ideally, the biomarkers should offer 
valuable information regarding the diagnostic and 
prognostic of patients and it should permit the monitoring 
of the patient’s response to the treatment [7, 8]. 
Numerous studies made on patients or animals 
with systemic inflammatory response syndrome of 
infectious origin, sustain the predictive potential of IL-6 
and TNF  [6, 9, 10], which have the capacity to predict 
the evolution towards septic complications [9, 11, 12].  
IL-6 is a proinflammatory mediator, whose 
quality of prediction was investigated in numerous studies 
[13, 14, 15]. Its plasma levels are susceptible to have 
predictive value for critical patients who have multiple 
organic dysfunction [13, 16, 18].  
By contrast, in a study made in the ICU, although 
the plasma levels of TNF  were high in patients with 
septic shock, a correlation between TNF  levels and the 
severity of the sepsis could not be established [17]. Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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